Case File
efta-efta00637206DOJ Data Set 9OtherFrom: Richard Kahn
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00637206
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Richard Kahn
To: "jeffrey E." <[email protected]>
Subject: Fwd: Jawbone Series 8 Investment Opportunity
Date: Wed, 19 Aug 2015 20:33:02 +0000
Richard Kahn
HBRK Associates Inc.
575 Lexington Avenue 4th Floor
New York NY 10022
Begin forwarded message:
From: Andrew Lindsay
Subject: Re: Jawbone Series 8 Investment Opportunity
Date: August 19, 2015 at 2:14:34 PM EDT
To: Richard Kahn <
Hi Richard,
I'm writing to follow-up on my previous e-mail about the Series 8 investment opportunity. While the
investment structure is relative complex, it provides a very compelling way for Mort to increase the preference
and seniority of its past investment while still participating in the upside. I want to be sure that you have a
chance to have all your questions about the round answered. We're also available to give you a broader and
more in-depth business update on the company's recent and projected performance.
Thanks,
Andrew
On Thu, Aug 13, 2015 at 12:24 PM, Andrew Lindsay
Richard,
I hope you're doing well and enjoying your summer.
> wrote:
As we previously discussed, Jawbone is closing the second portion of the investment from BlackRock and is concurrently raising
additional equity from insiders. The investment terms have been structured to present a compelling opportunity for existing
investors to participate in the future appreciation of Jawbone while also increasing and improving their downside protection.
Participating investors will receive Series 8 Preferred shares and an option to increase the value of the liquidation preference of
their previously-owned shares by convening them to Series 8 shares. Series 8 shares are Senior to all other shares except
Convertible Notes.
The capital raised will fund our growth in the rapidly-growing and dynamic wearable market. Our combination of a newly-
strengthened leadership team, sharpened focused and continued innovation puts us on the path for market success. Hosain and I
would love to share more details about our past and projected performance and the merits of the Series 8 investment opportunity.
Attached are a more detailed description of the transaction terms and the Series 8 SPA. It's not a simple transaction though and
we can discuss it in more detail on our call. As required by the IRA, you have 20 days to participate in the transaction.
EFTA00637206
Please let me know when you're available to continue the discussion.
Thanks,
Andrew
EFTA00637207
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01765224
0p
DOJ Data Set 11OtherUnknown
EFTA02328489
1p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA02125460
0p
DOJ Data Set 9OtherUnknown
From: "Jeffrey E." <[email protected]>
4p
DOJ Data Set 11OtherUnknown
EFTA02489202
1p
DOJ Data Set 10OtherUnknown
EFTA02086739
1p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.